資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/32611
|
| 標題: | Comparison of high-dose, short-course levofloxacin treatment vs conventional regimen against acute bacterial infection: meta-analysis of randomized controlled trials |
| 作者: | Chih-Wei Chen(陳志偉)
Chen, Yu-Hung
Cheng, I-Ling
Lai, Chih-Cheng |
| 貢獻者: | Chi Mei Med Ctr, Div Neurosurg, Dept Surg
Chia Nan Univ Pharm & Sci, Inst Ind Safety & Disaster Prevent, Dept Occupat Safety & Hlth, Coll Sustainable Environm
Chi Mei Med Ctr, Dept Pharm
Chi Mei Med Ctr, Dept Intens Care Med |
| 關鍵字: | levofloxacin
acute bacterial infection
community-acquired pneumonia
complicated urinary tract infection
acute sinusitis |
| 日期: | 2019 |
| 上傳時間: | 2020-07-29 13:52:03 (UTC+8) |
| 出版者: | DOVE MEDICAL PRESS LTD |
| 摘要: | Objects: This meta-analysis aims to assess the efficacy and safety of high-dose, short-dose levofloxacin in comparison with conventional therapy on treating acute bacterial infection. Methods: PubMed, Embase and Cochrane database were searched up to September 2018. Only randomized controlled trials (RCTs) evaluating high-dose, short-course levofloxacin and conventional regimen in the treatment of acute bacterial infection were included. The primary outcomes were clinical responses, microbiologic eradication and adverse effects. Results: Seven RCTs of 3,731 patients (1,835 in the high-dose, short-course levofloxacin regimen group and 1,896 in the conventional regimen group) were included. Overall, no significant difference between the high-dose, short-course levofloxacin regimen group and the conventional regimen was found in terms of clinical response (risk ratio, RR: 1.01; 95% CI: 0.98-1.04, I-2=10%). In addition, the high-dose, short-course levofloxacin regimen had a similar microbiological eradication rate to conventional regimen (RR: 1.02; 95% CI: 0.98-1.06, I-2=0%). Moreover, the high-dose, short-course levofloxacin regimen had a similar incidence of treatment-emergent adverse events to conventional regimen (RR: 1.07; 95% CI: 0.99-1.17, I-2=0%). This trend was not affected by the different types of infections-community-acquired pneumonia, complicated urinary tract infection/acute pyelonephritis or acute sinusitis, different conventional regimen-levofloxacin (500 mg daily for 7-14 days) or ciprofloxacin (400 mg IV or 500 mg oral, twice daily for 10 days). Conclusion: High-dose, short-course levofloxacin exhibits similar clinical success and microbiologic eradication rates with conventional regimen in the treatment of acute bacterial infection. Moreover, the high-dose, short-course levofloxacin regimen was well tolerated and had comparable safety profiles with the conventional regimen. |
| 關聯: | Infection and Drug Resistance, v.12, pp.1353-1361 |
| 顯示於類別: | [職業安全衛生系(含防災所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 10.2147-IDR.S193483.pdf | | 1255Kb | Adobe PDF | 387 | 檢視/開啟 | | index.html | | 0Kb | HTML | 931 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
